$RELI
Reliance Global Group, Inc. Stock $reli

$reli Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223018163 Filed on May 18, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$3.196M	$3.939M	$4.236M
YoY Change	-24.04%	-7.0%	84.16%
Cost Of Revenue	$822.3K	$1.083M	$904.2K
YoY Change	-3.28%	19.82%	70.6%
Gross Profit	$2.374M	$2.856M	$3.332M
YoY Change	-29.29%	-14.28%	88.23%
Gross Profit Margin	74.27%	72.5%	78.65%
Selling, General & Admin	$3.556M	$3.207M	$5.122M
YoY Change	-21.76%	-37.39%	162.68%
% of Gross Profit	149.83%	112.3%	153.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$767.4K	$541.9K	$607.5K
YoY Change	1.45%	-10.81%	84.1%
% of Gross Profit	32.33%	18.97%	18.24%
Operating Expenses	$5.034M	$4.832M	$5.730M
YoY Change	-18.17%	-15.67%	151.31%
Operating Profit	-$1.838M	-$893.0K	-$2.398M
YoY Change	-5.48%	-62.76%	370.23%
Interest Expense	-$370.9K
YoY Change	90.28%
% of Operating Profit
Other Income/Expense, Net	-$2.032M	$3.877M	$11.74M
YoY Change	-116.33%	-66.97%	-13142.41%
Pretax Income	-$3.870M	$2.984M	$9.340M
YoY Change	-136.87%	-68.05%	-1559.38%
Income Tax	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$1.055M	-$1.789M	$9.340M
YoY Change	-110.05%	-119.15%	-1621.36%
Net Earnings / Revenue	-33.02%	-45.4%	220.5%
Basic Earnings Per Share	-$0.39	-$1.15	$2.46
Diluted Earnings Per Share	-$0.39	-$1.15	$395.8K
COMMON SHARES
Basic Shares Outstanding	1.631M shares	1.566M shares	980.6K shares
Diluted Shares Outstanding	2.717M shares	2.186M shares	1.195M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.275M	$2.116M	$5.491M
YoY Change	-57.22%	-61.46%	-41.77%
Cash & Equivalents	$2.680M	$3.554M	$5.976M
Short-Term Investments
Other Short-Term Assets	$1.959M	$1.609M	$596.0K
YoY Change	-1.79%	170.05%	-5.4%
Inventory
Prepaid Expenses
Receivables	$978.9K	$982.0K	$1.175M
Other Receivables	$2.901M		$7.330K
Total Short-Term Assets	$7.132M	$4.708M	$7.270M
YoY Change	16.9%	-35.24%	-28.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$149.1K	$155.5K	$1.435M
YoY Change	-9.1%	-89.16%	102.08%
Goodwill	$14.29M	$14.29M
YoY Change	-57.33%
Intangibles	$12.31M	$12.89M
YoY Change	-16.56%
Long-Term Investments	$0.00	$900.0K	$1.350M
YoY Change	-100.0%	-33.33%	0.0%
Other Assets	$23.28K	$23.29K	$69.78K
YoY Change	0.0%	-66.63%
Total Long-Term Assets	$27.74M	$29.18M	$44.00M
YoY Change	-45.81%	-33.69%	163.15%
TOTAL ASSETS
Total Short-Term Assets	$7.132M	$4.708M	$7.270M
Total Long-Term Assets	$27.74M	$29.18M	$44.00M
Total Assets	$34.88M	$33.88M	$51.27M
YoY Change	-39.13%	-33.91%	91.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$911.3K	$1.077M	$824.1K
YoY Change	-13.32%	30.64%	333.75%
Accrued Expenses	$370.9K	$312.6K	$653.0K
YoY Change	-29.88%	-52.14%	988.38%
Deferred Revenue
YoY Change
Short-Term Debt	$195.0K	$38.31K	$0.00
YoY Change	-48.22%		-100.0%
Long-Term Debt Due	$1.329M	$1.235M	$918.1K
YoY Change	41.96%	34.53%	512.05%
Total Short-Term Liabilities	$4.865M	$5.451M	$7.835M
YoY Change	-48.63%	-30.43%	285.97%
LONG-TERM LIABILITIES
Long-Term Debt	$11.71M	$12.04M	$7.203M
YoY Change	-9.46%	67.08%	-7.88%
Other Long-Term Liabilities	$4.395M	$958.7K	$24.98M
YoY Change	-65.2%	-96.16%	773.35%
Total Long-Term Liabilities	$11.71M	$12.99M	$32.18M
YoY Change	-9.46%	-59.62%	201.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.865M	$5.451M	$7.835M
Total Long-Term Liabilities	$11.71M	$12.99M	$32.18M
Total Liabilities	$21.85M	$21.65M	$40.02M
YoY Change	-38.23%	-45.9%	214.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.84M	-$28.78M
YoY Change	119.02%
Common Stock	$176.5K	$134.7K
YoY Change	-85.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.03M	$12.24M	$11.25M
YoY Change
Total Liabilities & Shareholders Equity	$34.88M	$33.88M	$51.27M
YoY Change	-39.13%	-33.91%	91.16%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.055M	-$1.789M	$9.340M
YoY Change	-110.05%	-119.15%	-1621.36%
Depreciation, Depletion And Amortization	$767.4K	$541.9K	$607.5K
YoY Change	1.45%	-10.81%	84.1%
Cash From Operating Activities	-$942.2K	-$1.065M	-$343.3K
YoY Change	-2.68%	210.21%	-47.19%
INVESTING ACTIVITIES
Capital Expenditures	$84.28K	$6.695K	-$253.3K
YoY Change	-136.04%	-102.64%
Acquisitions
YoY Change
Other Investing Activities	$915.7K	-$15.71K	-$18.14M
YoY Change	-115.26%	-99.91%
Cash From Investing Activities	$831.4K	-$96.30K	-$18.39M
YoY Change	-113.34%	-99.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-763.2K	$2.806M	20.09M
YoY Change	-113.57%	-86.03%	98.13%
NET CHANGE
Cash From Operating Activities	-942.2K	-$1.065M	-343.3K
Cash From Investing Activities	831.4K	-$96.30K	-18.39M
Cash From Financing Activities	-763.2K	$2.806M	20.09M
Net Change In Cash	-874.0K	$1.645M	1.355M
YoY Change	-44.62%	21.36%
FREE CASH FLOW
Cash From Operating Activities	-$942.2K	-$1.065M	-$343.3K
Capital Expenditures	$84.28K	$6.695K	-$253.3K
Free Cash Flow	-$1.026M	-$1.072M	-$89.94K
YoY Change	39.79%	1091.43%	-86.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001812727
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent		usd
CY2023Q1	us-gaap	Other Liability Noncurrent Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Liability Noncurrent Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022Q1	RELI	Proceeds From Loans Payable Related Party Debt ProceedsFromLoansPayableRelatedPartyDebt		usd
CY2022Q1	RELI	Payments On Earnout Liabilities PaymentsOnEarnoutLiabilities		usd
CY2022Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2022Q1	RELI	Conversion Of Common Stock Into Repay Related Party Payable ConversionOfCommonStockIntoRepayRelatedPartyPayable		usd
CY2022Q1	RELI	Conversion Of Common Stock To Settle Earn Out Liabilities ConversionOfCommonStockToSettleEarnOutLiabilities		usd
CY2022Q1	RELI	Private Placement Equity Financing Cost Payable PrivatePlacementEquityFinancingCostPayable		usd
CY2023Q1	RELI	Issuance Of Series D Warrants IssuanceOfSeriesDWarrants		usd
CY2023Q1	RELI	Issuance Of Placement Agent Warrants IssuanceOfPlacementAgentWarrants		usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023Q1	RELI	Common Stock Issued Pursuant To Acquisition CommonStockIssuedPursuantToAcquisition		usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5450500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1788538	usd
CY2023Q1	RELI	Deemed Dividend DeemedDividend		usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	145662	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40020
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	RELIANCE GLOBAL GROUP, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3390293
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Blvd. of the Americas
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 105
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Lakewood
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08701
CY2023Q1	dei	City Area Code CityAreaCode	732
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	380-4600
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1631048	shares
CY2023Q1	us-gaap	Cash Cash	2116333	usd
CY2022Q4	us-gaap	Cash Cash	505410	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1437961	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1404359	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	11464	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	164154	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	245535	usd
CY2023Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	7354	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	85998	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4707763	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3265379	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	155511	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	162767	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	921531	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1018952	usd
CY2023Q1	us-gaap	Investments Investments	900000	usd
CY2022Q4	us-gaap	Investments Investments	900000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12889277	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9085092	usd
CY2023Q1	us-gaap	Goodwill Goodwill	14287099	usd
CY2022Q4	us-gaap	Goodwill Goodwill	14287099	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23285	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23284	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	9685156	usd
CY2023Q1	us-gaap	Assets Assets	33884466	usd
CY2022Q4	us-gaap	Assets Assets	38427729	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1076612	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	951382	usd
CY2023Q1	RELI	Short Term Financing Agreements ShortTermFinancingAgreements	38312	usd
CY2022Q4	RELI	Short Term Financing Agreements ShortTermFinancingAgreements	106817	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1182055	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1476113	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1235052	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1118721	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	312549	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339937	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1555692	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2153478	usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	50228	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1647836	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5450500	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7794284	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	958743	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1669515	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12035753	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12349673	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	638937	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	714068	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	398000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	556000	usd
CY2023Q1	RELI	Warrant Liabilities WarrantLiabilities	2166919	usd
CY2022Q4	RELI	Warrant Liabilities WarrantLiabilities	6433150	usd
CY2023Q1	us-gaap	Liabilities Liabilities	21648852	usd
CY2022Q4	us-gaap	Liabilities Liabilities	29516690	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.086
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	750000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.086
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.086
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	133333333	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	133333333	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1566048	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1566048	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1219573	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1219573	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	134660	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	104883	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40881475	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35798139	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28780521	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26991983	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12235614	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8911039	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33884466	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38427729	usd
CY2023Q1	RELI	Commission Income CommissionIncome	3939103	usd
CY2022Q1	RELI	Commission Income CommissionIncome	3058697	usd
CY2023Q1	us-gaap	Revenues Revenues	3939103	usd
CY2022Q1	us-gaap	Revenues Revenues	3058697	usd
CY2023Q1	RELI	Commission Expense CommissionExpense	1083326	usd
CY2022Q1	RELI	Commission Expense CommissionExpense	785611	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	1712097	usd
CY2022Q1	us-gaap	Salaries And Wages SalariesAndWages	1631813	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1358254	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2333795	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	136572	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	89529	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	541873	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	468278	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4832122	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	5309026	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-893019	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2250329	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	389351	usd
CY2022Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	107751	usd
CY2023Q1	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	4266231	usd
CY2022Q1	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	11845964	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3876880	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11738213	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2983861	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	9487884	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4772399	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-147884	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1788538	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	9340000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.92
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.61
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-3.07
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.15
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.46
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.59
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-9.57
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-2.18
CY2022Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.12
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-2.77
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-9.69
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1553953	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	980569	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2185847	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1195480	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8911039	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	43797	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	982478	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	645000	usd
CY2023Q1	RELI	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits	-4646	shares
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3446484	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1788538	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12235614	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12235614	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-26066129	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-26066129	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	739960	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	20000051	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4763451	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2475000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	9340000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	9340000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	11252333	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	11252333	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1788538	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	9340000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	541873	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	468279	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11721	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6467	usd
CY2023Q1	RELI	Noncash Lease Expense NoncashLeaseExpense	-5098	usd
CY2022Q1	RELI	Noncash Lease Expense NoncashLeaseExpense	2597	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	43797	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	739960	usd
CY2023Q1	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	4266231	usd
CY2022Q1	RELI	Recognition And Change In Fair Value Of Warrant Liability RecognitionAndChangeInFairValueOfWarrantLiability	11845964	usd
CY2023Q1	RELI	Earnout Fair Value And Writeoff Adjustments EarnoutFairValueAndWriteoffAdjustments	476692	usd
CY2022Q1	RELI	Earnout Fair Value And Writeoff Adjustments EarnoutFairValueAndWriteoffAdjustments	407071	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	125229	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1875191	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23976	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	48228	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-6676	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-5489	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-11464	usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	4361	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-294058	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1998	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	52992	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-81381	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2220963	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5031116	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-637908	usd
CY2023Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	3966238	usd
CY2022Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	294628	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1064878	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-343280	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6695	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	73894	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	249235	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-80589	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-249235	usd
CY2023Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-15708	usd
CY2022Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-18142858	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96297	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18392093	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	207580	usd
CY2022Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	227172	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	98004	usd
CY2023Q1	RELI	Proceeds From Loans Payable Related Party Debt ProceedsFromLoansPayableRelatedPartyDebt	345000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	412500	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	10770	usd
CY2023Q1	RELI	Payments On Earnout Liabilities PaymentsOnEarnoutLiabilities	250000	usd
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2475000	usd
CY2023Q1	RELI	Net Proceeds From Private Placement Issuance Of Shares And Warrants NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants	3446484	usd
CY2022Q1	RELI	Net Proceeds From Private Placement Issuance Of Shares And Warrants NetProceedsFromPrivatePlacementIssuanceOfSharesAndWarrants	17853351	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2823400	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	20090409	usd
CY2023Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-17700	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2805700	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20090409	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1644525	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1355036	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1909769	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4620722	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3554294	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5975758	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	382410	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	105447	usd
CY2023Q1	RELI	Conversion Of Common Stock Into Repay Related Party Payable ConversionOfCommonStockIntoRepayRelatedPartyPayable	645000	usd
CY2023Q1	RELI	Conversion Of Common Stock To Settle Earn Out Liabilities ConversionOfCommonStockToSettleEarnOutLiabilities	982478	usd
CY2023Q1	RELI	Private Placement Equity Financing Cost Payable PrivatePlacementEquityFinancingCostPayable	552618	usd
CY2022Q1	RELI	Issuance Of Series D Warrants IssuanceOfSeriesDWarrants	6930335	usd
CY2022Q1	RELI	Issuance Of Placement Agent Warrants IssuanceOfPlacementAgentWarrants	1525923	usd
CY2022Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	281815	usd
CY2022Q1	RELI	Common Stock Issued Pursuant To Acquisition CommonStockIssuedPursuantToAcquisition	4763451	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	484351	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3554294	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5975758	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.59
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-9.57
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3554000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4708000	usd
CY2023Q1	RELI	Working Capital Deficiency WorkingCapitalDeficiency	-742000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12236000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-893000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4266000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2984000	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4772000	usd
CY2023Q1	RELI	Net Proceeds From Private Placement Issuance Of Value And Warrant NetProceedsFromPrivatePlacementIssuanceOfValueAndWarrant	-3446000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z5ZpgNH7VkX2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86C_zPH8jABdgnQ6">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash Cash	2116333	usd
CY2022Q1	us-gaap	Cash Cash	5491407	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1437961	usd
CY2021Q4	RELI	Warrant Commitment WarrantCommitment	37652808	usd
CY2022	RELI	Initial Recognition Of Warrant Commitment InitialRecognitionOfWarrantCommitment	56587043	usd
CY2022	RELI	Warrant Commitment Unrealized Gain Loss WarrantCommitmentUnrealizedGainLoss	-32737582	usd
CY2022	RELI	Warrants Exercised Or Transferred WarrantsExercisedOrTransferred	-55069119	usd
CY2022Q4	RELI	Warrant Commitment WarrantCommitment	6433150	usd
CY2023Q1	RELI	Warrant Commitment Unrealized Gain Loss WarrantCommitmentUnrealizedGainLoss	4266231	usd
CY2023Q1	RELI	Warrant Commitment WarrantCommitment	2166919	usd
CY2023Q1	RELI	Earn Out Payments EarnOutPayments	2123442	usd
CY2023Q1	RELI	Earnout Liability Current EarnoutLiabilityCurrent	-1555692	usd
CY2022Q4	RELI	Earnout Liability Current EarnoutLiabilityCurrent	-2153478	usd
CY2023Q1	RELI	Earnout Liability Noncurrent EarnoutLiabilityNoncurrent	398000	usd
CY2022Q4	RELI	Earnout Liability Noncurrent EarnoutLiabilityNoncurrent	556000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3939103	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3058697	usd
CY2021Q4	us-gaap	Goodwill Goodwill	10050277	usd
CY2022Q4	us-gaap	Goodwill Goodwill	14287099	usd
CY2023Q1	us-gaap	Goodwill Goodwill	14287099	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19673204	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6783927	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12889277	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14824633	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-5739541	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9085092	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	38000	usd
CY2022Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1914714	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2177765	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1783809	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1515517	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1182581	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4314891	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12889277	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	13270805	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	13468394	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1235052	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1118721	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12035753	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	12349673	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	893877	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1411275	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1567542	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1736878	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1924523	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	6040548	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13574643	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	303838	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	13270805	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	154000	usd
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0	pure
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	133333333	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.086
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-15 reverse split
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1566048	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1219573	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.15
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.086
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2023Q1	RELI	Gross Proceeds Cash Fee GrossProceedsCashFee	8	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3400000	usd
CY2023Q1	RELI	Direct Financing Fee DirectFinancingFee	553000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2667	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5842	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	43797	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	739960	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2983861	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	9487884	usd
CY2022Q1	RELI	Deemed Dividend DeemedDividend	-6930335	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2983861	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2557549	usd
CY2023Q1	RELI	Recognition And Change In Fair Value Of Warrant Liabilities RecognitionAndChangeInFairValueOfWarrantLiabilities	-4266231	usd
CY2022Q1	RELI	Recognition And Change In Fair Value Of Warrant Liabilities RecognitionAndChangeInFairValueOfWarrantLiabilities	-13992664	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1282370	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11435115	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1553953	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	980569	shares
CY2023Q1	RELI	Effect Of Series B Warrants EffectOfSeriesBWarrants	631894	shares
CY2022Q1	RELI	Effect Of Series B Warrants EffectOfSeriesBWarrants	214911	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2185847	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1195480	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.92
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.61
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	161614	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y10M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0560	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	271267	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	269908	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	144124	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	113738	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	117150	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	151052	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1067239	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	115753	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	951486	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2709478	usd
CY2023Q1	RELI	Changes Due To Payments ChangesDueToPayments	-1232478	usd
CY2023Q1	RELI	Changes Due To Fair Value Adjustments ChangesDueToFairValueAdjustments	476692	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1953692	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3813878	usd
CY2022Q1	RELI	Changes Due To Business Combinations ChangesDueToBusinessCombinations	600000	usd
CY2022Q1	RELI	Changes Due To Payments ChangesDueToPayments	-1704925	usd
CY2022Q1	RELI	Changes Due To Fair Value Adjustments ChangesDueToFairValueAdjustments	525	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2709478	usd
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	262684	shares

Files In Submission

Name	View Source	Status
0001493152-23-018163-index-headers.html	Edgar Link	pending
0001493152-23-018163-index.html	Edgar Link	pending
0001493152-23-018163.txt	Edgar Link	pending
0001493152-23-018163-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
reli-20230331.xsd	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
reli-20230331_cal.xml	Edgar Link	unprocessable
reli-20230331_def.xml	Edgar Link	unprocessable
reli-20230331_lab.xml	Edgar Link	unprocessable
reli-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RELI
Reliance Global Group, Inc. Stock $reli

2023 Q2 Form 10-Q Financial Statement

#000149315223018163 Filed on May 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RELI Reliance Global Group, Inc. Stock $reli

2023 Q2 Form 10-Q Financial Statement

#000149315223018163 Filed on May 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RELI
Reliance Global Group, Inc. Stock $reli